China Regulator Backs Quality of Local Generic Medicines Amid Safety Concerns
2025-02-10
Reuters on MSN.com
China's health regulator has come to the defence of locally-made generic drugs, stating that an investigation into quality concerns has found no evidence to substantiate the claims. The regulator's move aims to boost confidence in the country's pharmaceutical industry, which has faced scrutiny over the efficacy of off-patent medicines. With the healthcare sector being a significant concern for the Chinese government, generic medicines play a vital role in making healthcare more accessible and affordable for the population, highlighting the importance of pharmaceutical quality control and healthcare regulation in the country's public health system. The regulator's findings are expected to alleviate concerns over drug safety and efficacy.
